Homoeopathic medicines for neck pain
- Conditions
- Cervicalgia,
- Registration Number
- CTRI/2023/04/051991
- Lead Sponsor
- The Calcutta Homoeopathic Medical College and Hospital
- Brief Summary
The WHO Global Burden of Disease study showed that neck pain is the 8th rankedreason for most years lived with disability for 15–19 year old of any healthcondition, which is higher than well-known adolescent public health problems. Theimpact of neck pain is significant not just for the individual, but also forindustry and society. This 3-months, double-blind, randomized (1:1), placebo-controlled trial of individualized homeopathic medicines against placebos will be carried out at The Calcutta Homoeopathic Medical College & Hospital on 74 participants with chronic neck pain. Primary outcome is Pain Detect Questionnaire (PDQ); secondary outcome is EQ-5D-5L questionnaire and VAS scores; all to be measured at baseline, and every month, up to 3 months. Comparative analysis will be carried out to detect group differences. Results will be published in scientific journals.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- All
- Target Recruitment
- 74
- Patients suffering from chronic neck pain for 3 months or more.
- Age between 10 and 65 years 3.
- Patients of either sex, including transgender 4.
- Literate patients; ability to read English, Bengali or Hindi and illiterate people will be interviewed by the investigators maintaining adequate privacy to fill up the scales or questionnaires 5.
- Willing to take part in the study and give written informed assent and/or consent voluntarily.
-
- Patients with known cervical radiculopathy (using spurling test) or having any severe pathological conditions causing neck pain. (e.g., cervical spondylosis, kyphosis, scoliosis, history of spinal injury, disc prolapse etc.) 2. Patients suffering from autoimmune disorders that impacts the musculoskeletal system (e.g., lupus, rheumatoid arthritis, ankylosing spondylitis) 3. Patients who are undergoing treatment with NSAIDs during 6 weeks prior to enrolment in the study. 4. Patients having history of any degenerative muscular or neurological condition that can impact the outcome measure (e.g., Parkinson’s disease, amyotrophic lateral sclerosis, multiple sclerosis, different myelopathy, muscular dystrophy, etc.) 5. Patients taking spinal corticosteroid injection within 6 months. 6. Patients suffering from active or chronic, systemic, or local infection or disease. 7. The chronic neck pain is due to any invasive malignant disease/neoplasia. 8. Vulnerable population.
- unconscious, non-ambulatory, too ill for consultation, differently abled, terminally ill or critically ill patients, institutionalized persons, mentally disabled people. 9. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness or serious illness (like cardiac disease) affecting the quality of life or organ failure. 10. Pregnant and postpartum women, lactation. 11. Patients with the habit of tobacco chewing and/or smoking, alcoholism and/or any other forms of substance abuse and/or dependence. 12. Self-reported immune-compromised condition. 13. Already been in homeopathic treatment for any chronic illness for the last 6 months. 14. Simultaneous participation in any other clinical trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain Detect Questionnaire (PDQ) At baseline, every month, up to 3 months
- Secondary Outcome Measures
Name Time Method EQ-5D-5L VAS At baseline, every month, up to 3 months EQ-5D-5L questionnaire At baseline, every month, up to 3 months
Trial Locations
- Locations (1)
The Calcutta Homoeopathic Medical College and Hospital
🇮🇳Kolkata, WEST BENGAL, India
The Calcutta Homoeopathic Medical College and Hospital🇮🇳Kolkata, WEST BENGAL, IndiaRitika BosePrincipal investigator7688010574parionthenet@gmail.com